US Food and Drug Administration has allowed the U.S. to the worst cases of influenza A/H1N1 was the medication, which clinical trials have not yet been completed. It's about Peramvir - a measure produced by the little-known biotech company in Alabama.

Procedure for release on the market has not yet been completed. However, the government has decided to use it in the face of a growing number of severe cases. As reported by The New York Times, Peramvir to be used in hospitals for patients who do not help either Tamiflu or Relenza.

Perhaps in the wake of this decision we will find out quickly whether Peramvir actually increase the chances of cure for people undergoing hard not only new, but the seasonal flu.